Dr Lawrence Osei, MD | |
10 Hospital Dr, Dept Anesthesiology, Saint Peters, MO 63376-1659 | |
(800) 862-9980 | |
(314) 362-1185 |
Full Name | Dr Lawrence Osei |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 28 Years |
Location | 10 Hospital Dr, Saint Peters, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093991887 | NPI | - | NPPES |
207166307 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | 2011033544 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hospital | Belleville, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Washington University Physicians In Illinois, Inc | 4789945163 | 98 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
The Juvenile Diabetes Research Foundation (JDRF), the world's leading charitable funder of research leading to a cure of type 1 diabetes and its complications, held the Global Diabetes Research Forum today as part of its annual meeting in Washington, DC.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Inherited ventricular arrhythmias are an important cause of morbidity and sudden cardiac death in children who have structurally normal hearts. Despite conventional medical therapy, some of these children remain symptomatic with recurrent life-threatening arrhythmias, syncope, or frequent discharges from implantable cardioverter defibrillators.
SomaLogic, Inc., announced today that it has entered into a multi-year research agreement with Novartis to use its unique proprietary proteomics technology to accelerate Novartis' drug discovery and development efforts.
› Verified 7 days ago
Entity Name | Cep America Illinois Intensivists |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821641499 PECOS PAC ID: 0345535449 Enrollment ID: O20160829002157 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
The Juvenile Diabetes Research Foundation (JDRF), the world's leading charitable funder of research leading to a cure of type 1 diabetes and its complications, held the Global Diabetes Research Forum today as part of its annual meeting in Washington, DC.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Inherited ventricular arrhythmias are an important cause of morbidity and sudden cardiac death in children who have structurally normal hearts. Despite conventional medical therapy, some of these children remain symptomatic with recurrent life-threatening arrhythmias, syncope, or frequent discharges from implantable cardioverter defibrillators.
SomaLogic, Inc., announced today that it has entered into a multi-year research agreement with Novartis to use its unique proprietary proteomics technology to accelerate Novartis' drug discovery and development efforts.
› Verified 7 days ago
Entity Name | Washington University Physicians In Illinois, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477076263 PECOS PAC ID: 4789945163 Enrollment ID: O20180227002018 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
The Juvenile Diabetes Research Foundation (JDRF), the world's leading charitable funder of research leading to a cure of type 1 diabetes and its complications, held the Global Diabetes Research Forum today as part of its annual meeting in Washington, DC.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Inherited ventricular arrhythmias are an important cause of morbidity and sudden cardiac death in children who have structurally normal hearts. Despite conventional medical therapy, some of these children remain symptomatic with recurrent life-threatening arrhythmias, syncope, or frequent discharges from implantable cardioverter defibrillators.
SomaLogic, Inc., announced today that it has entered into a multi-year research agreement with Novartis to use its unique proprietary proteomics technology to accelerate Novartis' drug discovery and development efforts.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lawrence Osei, MD 660 S Euclid Ave, Cb 8054, Saint Louis, MO 63110-1010 Ph: (800) 862-9980 | Dr Lawrence Osei, MD 10 Hospital Dr, Dept Anesthesiology, Saint Peters, MO 63376-1659 Ph: (800) 862-9980 |
News Archive
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
The Juvenile Diabetes Research Foundation (JDRF), the world's leading charitable funder of research leading to a cure of type 1 diabetes and its complications, held the Global Diabetes Research Forum today as part of its annual meeting in Washington, DC.
Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors respond to dietary restriction during their development.
Inherited ventricular arrhythmias are an important cause of morbidity and sudden cardiac death in children who have structurally normal hearts. Despite conventional medical therapy, some of these children remain symptomatic with recurrent life-threatening arrhythmias, syncope, or frequent discharges from implantable cardioverter defibrillators.
SomaLogic, Inc., announced today that it has entered into a multi-year research agreement with Novartis to use its unique proprietary proteomics technology to accelerate Novartis' drug discovery and development efforts.
› Verified 7 days ago
Furqan F Raja, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 Jungermann Circle, Suite 405, Saint Peters, MO 63376 Phone: 636-720-0310 Fax: 636-720-0311 | |
Dr. Pierre Moeser, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 Jungermann Cir, Ste 300, Saint Peters, MO 63376 Phone: 636-916-9020 Fax: 636-916-9021 | |
Dr. Ron Javdan, M.D. Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 6 Jungermann Cir, Suite 203, Saint Peters, MO 63376 Phone: 636-928-1822 Fax: 636-441-7033 | |
Dr. Anna Roshal, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 150 Entrance Way, Saint Peters, MO 63376 Phone: 636-916-9920 Fax: 636-916-9176 | |
Dr. Sandeep Hindupur, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr Ste 100, Saint Peters, MO 63376 Phone: 636-916-7272 | |
April Thebeau, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 314-317-0600 Fax: 314-317-0606 |